Some Good News - Health Canada has approved Ib... - CLL Support
Some Good News - Health Canada has approved Ibrutinib & Venetoclax as a first line treatment for previously untreated CLL/SLL.
You need to be a member of this community to see this post.
8 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Venetoclax plus obinutuzumab - the first chemotherapy-free, fixed-duration first line CLL treatment approved by Health Canada
* VENCLEXTA® (venetoclax) plus obinutuzumab is the first chemotherapy-free,
fixed-duration...
B-PLL: Ibrutrinib Monotherapy or Obinutuzumab (aka Gazyva) & Venetoclax Combination as first-line treatment for transformed CLL
Hi Everyone,
I'm new to this group. My Dad has CLL with a B-PLL transformation in his lymph nodes....
Ibrutinib-Venetoclax is the recommended first-line therapy for fit Arab patients with CLL in the Gulf region
A group of CLL experts from across the Gulf region and an international expert from Germany have...
How you can help make ibrutinib plus venetoclax fixed duration therapy a reality for Australians with previously untreated CLL
In Australia, no new medicine can be listed on the Pharmaceutical Benefits Scheme (PBS) unless it...
FDA Frontline Approval of Venetoclax and Obinituzumab in the USA
Hi,
Venetoclax in combination with obinutuzumab has been approved frontline for CLL. This is the...
Related Posts
Looking for a resource re treatment for CLL/SLL- Health Canada approves Ibrutinib plus Rituximab for First Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease
A cautionary tale about using AI - UK NICE Approves Ibrutinib +Venetoclax for First Line treatment for ALL Patients from today
